Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro
about
Host immunity to Cryptococcus neoformansCryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformansThe cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes.Lymphocyte adhesion to Candida albicansEarly expression of local cytokines during systemic Candida albicans infection in a murine intravenous challenge model.Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response.Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice.Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytesMechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharidegamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicansBinding of Cryptococcus neoformans to heterologously expressed human complement receptors.A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis.Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production.Host defence to pulmonary mycosisDirect activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanismDirect microbicidal activity of cytotoxic T-lymphocytes.Host defenses against cryptococcosis.Immunotherapy of Fungal Infections.Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.Polysaccharide antigens of the capsule of Cryptococcus neoformans.Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity.A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung.Late expression of granulysin by microbicidal CD4+ T cells requires PI3K- and STAT5-dependent expression of IL-2Rbeta that is defective in HIV-infected patients.Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection.Anticryptococcal cytotoxicity of murine nonadherent cells is perforin and nonperforin mediated.Adaptive Immunity to Cryptococcus neoformans Infections.
P2860
Q26823438-C84A0A79-0FE4-47FD-B214-03F46B503C6DQ30424017-E3E8BA27-E720-4904-A348-0911DC17F521Q33754495-4852FE4D-6900-4931-9EA5-EA6C643D5DC6Q34000431-25D0D36A-A966-4D42-966B-E579B1F275FDQ34117023-690E4CD5-31A7-4E77-B78E-D62BA0C70E8DQ34265612-1C7FAD2E-2DB5-4401-A335-B885F4F4C295Q34530361-23B569BA-D889-477B-9672-D7F5E48CE283Q35406646-71349AD3-0D24-4113-A3EB-E1AB907D9A5EQ35411136-A4C51E27-0534-417D-8D11-1BBAF76495E5Q35427625-BE7018A5-37F7-493B-B64D-C56C713F00E3Q35437735-A32D4216-2DDE-422A-A87D-80225374BC45Q35475646-CECC1D03-1DFA-40C6-A4BC-3B60248E6988Q35488223-A1BF7960-7A2E-498C-A6AA-82F30C2D9521Q35544049-3ACA5B7E-6A91-47A6-976B-B648A7F75E40Q35556088-9CE99965-B3D5-4FBC-941C-B1C355BD8553Q35557759-3CA72378-1B9B-4D28-94FB-11F5FC70879CQ35649657-2543C1D6-1DEE-49CC-A013-65C941109148Q35771518-91B3C136-B6FE-4A39-8B6B-6B9623373D14Q36047782-7CA23AB8-9EF2-4A13-A7F7-E01312DA4C25Q36363319-9C37F2D1-60A6-4ECA-8A4A-E4DA24424715Q37771265-4B2FC254-8EE6-45B7-A417-0C20F6DEBC71Q37943849-841978FD-B9AD-4534-9128-AD168F7A7D8BQ38635409-735A8471-3D2B-49F2-BC66-CFEC9D807A47Q39825246-FCEB19CD-C71F-411A-9C08-04142CC18C19Q39859915-3E6F3FF5-6F79-4A26-8766-F4AFA155E6B1Q39860295-49C8A515-FE2F-43F3-956D-D3765AF1793BQ39869331-CE67B3C3-F8D6-43D1-A257-A6AD14B9432BQ40269925-981F8268-8391-4467-8314-A80FF7ED75E8Q41842695-8D86263C-2544-4141-B8C5-B1A8EE4F8482Q44555493-2C650761-928F-4368-A737-F3A3BC4B407AQ44674812-D9541B56-CE2F-4B1A-A428-02988F47F791Q49188733-4D5CEFAE-AF0D-4FAE-AE8D-6859F4F0F632
P2860
Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Phenotypic and functional char ...... yptococcus neoformans in vitro
@ast
Phenotypic and functional char ...... yptococcus neoformans in vitro
@en
type
label
Phenotypic and functional char ...... yptococcus neoformans in vitro
@ast
Phenotypic and functional char ...... yptococcus neoformans in vitro
@en
prefLabel
Phenotypic and functional char ...... yptococcus neoformans in vitro
@ast
Phenotypic and functional char ...... yptococcus neoformans in vitro
@en
P2860
P356
P1476
Phenotypic and functional char ...... yptococcus neoformans in vitro
@en
P2093
M P Dupont
S M Levitz
P2860
P304
P356
10.1172/JCI116354
P407
P577
1993-04-01T00:00:00Z